The liver-specific deletion of FIP200/RB1CC1 was reported to suppress lipid accumulation, to decrease lipogenic gene expression, and to exacerbate LPS and endotoxin-induced liver injury in an NAFLD mouse model (Table 3) [432]. Here, RB1CC1 is linked to metabolic dysfunction-associated steatotic liver disease.